company background image
KVUE logo

Kenvue NYSE:KVUE Stock Report

Last Price

US$21.20

Market Cap

US$40.6b

7D

-1.5%

1Y

-0.7%

Updated

05 Jan, 2025

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$25.09
FV
15.5% undervalued intrinsic discount
8.70%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
2 months ago author updated this narrative

Kenvue Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Kenvue
Historical stock prices
Current Share PriceUS$21.20
52 Week HighUS$24.46
52 Week LowUS$17.67
Beta0
1 Month Change-7.18%
3 Month Change-3.59%
1 Year Change-0.70%
3 Year Changen/a
5 Year Changen/a
Change since IPO-21.19%

Recent News & Updates

Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 70% Above Its Share Price

Jan 04
Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 70% Above Its Share Price

Kenvue (NYSE:KVUE) Seems To Use Debt Quite Sensibly

Dec 08
Kenvue (NYSE:KVUE) Seems To Use Debt Quite Sensibly

Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)

Nov 27

Recent updates

Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 70% Above Its Share Price

Jan 04
Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 70% Above Its Share Price

Kenvue (NYSE:KVUE) Seems To Use Debt Quite Sensibly

Dec 08
Kenvue (NYSE:KVUE) Seems To Use Debt Quite Sensibly

Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)

Nov 27

Kenvue: Unpacking Activist's Case And Earnings Preview

Oct 29

Kenvue (NYSE:KVUE) Has Affirmed Its Dividend Of $0.205

Oct 22
Kenvue (NYSE:KVUE) Has Affirmed Its Dividend Of $0.205

Investors Met With Slowing Returns on Capital At Kenvue (NYSE:KVUE)

Oct 07
Investors Met With Slowing Returns on Capital At Kenvue (NYSE:KVUE)

Kenvue: Turning Cautious On The Stock While Remaining Optimistic On The Business

Oct 02

Kenvue (NYSE:KVUE) Has A Pretty Healthy Balance Sheet

Sep 08
Kenvue (NYSE:KVUE) Has A Pretty Healthy Balance Sheet

Kenvue: Promising Steps Toward Long-Term Success

Aug 11

Kenvue Is A Premier Consumer Company, But I Am Waiting For A Lower Price Before I Buy

Aug 02

Is There An Opportunity With Kenvue Inc.'s (NYSE:KVUE) 36% Undervaluation?

Jul 15
Is There An Opportunity With Kenvue Inc.'s (NYSE:KVUE) 36% Undervaluation?

Kenvue: A 4% Yield Worth Going Long

Jun 12

Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

May 21
Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

Kenvue Q1 Earnings Preview: A Potentially Troubling Trend

May 03

Kenvue: Fairly Valued Spinout

Apr 17

Is Kenvue Inc. (NYSE:KVUE) Trading At A 31% Discount?

Apr 08
Is Kenvue Inc. (NYSE:KVUE) Trading At A 31% Discount?

Kenvue: This Dividend Newcomer Is Worth A Look

Feb 13

Kenvue: What To Expect From Its First Full-Year Report As A Standalone Company

Feb 05

Kenvue: Portfolio Filled Of Market Leaders

Dec 20

Kenvue: Dude, Where's My Dividend Growth?

Nov 26

Kenvue: Only A Watchlist Stock For Now

Nov 19

Kenvue: Consumer Health Giant's Journey From IPO To Legal Challenges And Beyond

Oct 19

Kenvue: Interesting Times

Sep 18

Kenvue: Charting A Healthy Future In Consumer Health

Sep 06

Kenvue Split-Off: Still Undecided? 3 (And A Half) Aspects To Consider

Aug 16

Kenvue: A Buffett-Style Investment At A Reasonable Price

Jul 11

Johnson & Johnson Spinoff Kenvue Is Worth Owning - But Maybe Not Yet

Jun 13

Shareholder Returns

KVUEUS Personal ProductsUS Market
7D-1.5%-2.2%-0.2%
1Y-0.7%-24.7%25.6%

Return vs Industry: KVUE exceeded the US Personal Products industry which returned -24.7% over the past year.

Return vs Market: KVUE underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is KVUE's price volatile compared to industry and market?
KVUE volatility
KVUE Average Weekly Movement3.1%
Personal Products Industry Average Movement8.1%
Market Average Movement6.3%
10% most volatile stocks in US Market18.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: KVUE has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: KVUE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
202222,000Thibaut Mongonwww.kenvue.com

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Kenvue Inc. Fundamentals Summary

How do Kenvue's earnings and revenue compare to its market cap?
KVUE fundamental statistics
Market capUS$40.65b
Earnings (TTM)US$1.06b
Revenue (TTM)US$15.46b

38.2x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KVUE income statement (TTM)
RevenueUS$15.46b
Cost of RevenueUS$6.51b
Gross ProfitUS$8.95b
Other ExpensesUS$7.89b
EarningsUS$1.06b

Last Reported Earnings

Sep 29, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.55
Gross Margin57.90%
Net Profit Margin6.88%
Debt/Equity Ratio80.7%

How did KVUE perform over the long term?

See historical performance and comparison

Dividends

3.9%

Current Dividend Yield

145%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 01:43
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kenvue Inc. is covered by 20 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Lauren LiebermanBarclays
Navann Ty DietschiBNP Paribas Exane